TrialCardiovascular therapeutics2022

Simvastatin Combined with Resistance Training Improves Outcomes in Patients with Chronic Heart Failure by Modulating Mitochondrial Membrane Potential and the Janus Kinase/Signal Transducer and Activator of Transcription 3 Signaling Pathways.

Xiaowen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.